Redian新闻
>
Re: Investing ViroLogic (VLGC)
avatar
Re: Investing ViroLogic (VLGC)# Investment - 投资
v*x
1
small biopharm companies are usually totally different species
from most other growth stocks. they are mostly event driven and
less likely be affected by market trend. so I don't know if
your criteria fit well for this sector.
as for VLGC, the selling point is anti-viral assay. If I remember
correctly, CDC's '02 figure for this market is about $300 million.
Major players are those big pharmas such as JNJ, LLY, ABT, etc.
For what I read (patent search), VLGC's pipeline does not have
much niche st
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。